Intralesional Infiltrations of Cell-Free Filtrates Derived from Human Diabetic Tissues Delay the Healing Process and Recreate Diabetes Histopathological Changes in Healthy Rats
Jorge Berlanga‐Acosta(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Ariana García‐Ojalvo(Centro de Ingeniería Genética y Biotecnología), Yssel Mendoza‐Marí(Western University of Health Sciences), Maday Fernández‐Mayola(Centro de Ingeniería Genética y Biotecnología), Raymond J. Playford(University of West London)
Cited by 11
Related Papers
Newly identified genetic risk variants for celiac disease related to the immune response
|Nature Genetics|2008|690
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
Synergistic enhancement of Toll-like receptor responses by NOD1 activation
|European Journal of Immunology|2005|157
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153